메뉴 건너뛰기




Volumn 11, Issue 4, 2014, Pages 595-601

Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AigisRx antibacterial envelope

Author keywords

Cardiac implantable electronic device; Infection

Indexed keywords

ANTIBIOTIC AGENT;

EID: 84897086014     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.12.013     Document Type: Article
Times cited : (133)

References (15)
  • 1
    • 76649138577 scopus 로고    scopus 로고
    • Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association
    • on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and the Interdisciplinary Council on Quality of Care and Outcomes Research
    • Baddour LM, Epstein AE, Erickson CC, et al, on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and the Interdisciplinary Council on Quality of Care and Outcomes Research. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458-477.
    • (2010) Circulation , vol.121 , pp. 458-477
    • Baddour, L.M.1    Epstein, A.E.2    Erickson, C.C.3
  • 2
    • 80052087661 scopus 로고    scopus 로고
    • 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008
    • Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol 2011;58:1001-1006.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 1001-1006
    • Greenspon, A.J.1    Patel, J.D.2    Lau, E.3
  • 3
    • 77950508753 scopus 로고    scopus 로고
    • Continued rise in rates of cardiovascular implantable electronic device infections in the Unitd States: Temporal trends and causative insights
    • Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the Unitd States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-419.
    • (2010) Pacing Clin Electrophysiol , vol.33 , pp. 414-419
    • Voigt, A.1    Shalaby, A.2    Saba, S.3
  • 4
    • 33645227123 scopus 로고    scopus 로고
    • Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery
    • Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-145.
    • (2006) Pacing Clin Electrophysiol , vol.29 , pp. 142-145
    • Bloom, H.1    Heeke, B.2    Leon, A.3
  • 7
    • 65549099614 scopus 로고    scopus 로고
    • Risk factors and time delay associated with cardiac device infections: Leiden device registry
    • Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95:715-720.
    • (2009) Heart , vol.95 , pp. 715-720
    • Lekkerkerker, J.C.1    Van Nieuwkoop, C.2    Trines, S.A.3
  • 8
    • 84871197049 scopus 로고    scopus 로고
    • Risk factors for infection of implantable cardiac devices: Data from a registry of 2496 patients
    • Hercé B, Nazeyrollas P, Lesaffre F, et al. Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients. Europace 2013;15:66-70.
    • (2013) Europace , vol.15 , pp. 66-70
    • Hercé, B.1    Nazeyrollas, P.2    Lesaffre, F.3
  • 10
    • 69149091691 scopus 로고    scopus 로고
    • Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial
    • De Oliveira JC, Martinelli M, Nishioka SAD, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter- defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:29-34.
    • (2009) Circ Arrhythm Electrophysiol , vol.2 , pp. 29-34
    • De Oliveira, J.C.1    Martinelli, M.2    Nishioka, S.A.D.3
  • 11
    • 67650669013 scopus 로고    scopus 로고
    • In vivo model of human pathogen infection and demonstration of efficiacy by an antimicrobial pouch for pacing devices
    • Hansen LK, Brown M, Johnson D, et al. In vivo model of human pathogen infection and demonstration of efficiacy by an antimicrobial pouch for pacing devices. Pacing Clin Electrophysiol 2009;32:898-907.
    • (2009) Pacing Clin Electrophysiol , vol.32 , pp. 898-907
    • Hansen, L.K.1    Brown, M.2    Johnson, D.3
  • 12
    • 79951471478 scopus 로고    scopus 로고
    • Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope
    • for the COMMAND (COoperative Multicenter study Monitoring a CIED ANtimicrobial Device) Investigators.
    • Bloom HL, Constantin L, Dan D, et al, for the COMMAND (COoperative Multicenter study Monitoring a CIED ANtimicrobial Device) Investigators. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011;34:133-142.
    • (2011) Pacing Clin Electrophysiol , vol.34 , pp. 133-142
    • Bloom, H.L.1    Constantin, L.2    Dan, D.3
  • 13
    • 84874765584 scopus 로고    scopus 로고
    • Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high risk patients
    • Kolek MJ, Dresen WF, Wells QS, Ellis CR. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high risk patients. Pacing Clin Electrophysiol 2013;36:354-361.
    • (2013) Pacing Clin Electrophysiol , vol.36 , pp. 354-361
    • Kolek, M.J.1    Dresen, W.F.2    Wells, Q.S.3    Ellis, C.R.4
  • 14
    • 73849120250 scopus 로고    scopus 로고
    • Contemporary management of and outcomes from cardiac device related infections
    • Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace 2010;12:64-70.
    • (2010) Europace , vol.12 , pp. 64-70
    • Margey, R.1    McCann, H.2    Blake, G.3
  • 15
    • 67649786427 scopus 로고    scopus 로고
    • The Society of Thoracic Surgeons 2008 cardiac surgery risk models, Part 3: Valve plus coronary artery bypass grafting surgery
    • Society of Thoracic Surgeons Quality Measurement Task Force
    • Shahian DM, O'Brien SM, Filardo G, et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models, Part 3: valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88:S43-S62.
    • (2009) Ann Thorac Surg , vol.88
    • Shahian, D.M.1    O'Brien, S.M.2    Filardo, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.